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ABSTRACT
INTRODUCTION: Rotaviruses are a leading cause of diarrheal mortality in children less than five years 
old. Mixed forms with other intestinal pathogens have been reported, interfering with the severity and out-
come of the illness. 
AIM: The aim of this article is to analyze the characteristics of mixed infections among rotaviruses and 
other intestinal pathogens. 
MATERIALS AND METHODS: Twenty-seven patients up to 5 years of age, diagnosed with a co-infection 
from the rotavirus group and other intestinal pathogens were analyzed during the period from March, 2016 
to December, 2017. A clinical epidemiologic study was conducted. The diagnosis was made by stool cultures 
for bacterial pathogens/feces analyses for viral antigens in the microbiology/virus laboratory of the St. Ma-
rina University Hospital, Varna. Statistic methods were used for data processing. 
RESULTS: For the aforementioned period, 483 patients, up to 5 years of age, with rotaviral gastroenteritis 
were hospitalized. Mixed forms of intestinal infection were registered in 27 children (5.59%). Early child-
hood (between 1 to 3 years of age) was the most commonly affected age group. Cases were separated into two 
groups: rotavirus-virus association and rotavirus-bacterium association. Cases with rotavirus-virus associ-
ation were more predominant (55.6%) than rotavirus-bacterium ones (44.4%). The clinical presentation in-
cluded fever, vomiting, diarrhea, and lasted 6.53±1.53 days among the patients in the first studied group. In 
rotavirus-bacterium mixed infections vomiting was not a generally present symptom, but distinct compli-
cations ordinary occurred (83.33%) and the average hospitalization period was 10±1.98 days. 
CONCLUSION: Mixed infections including rotavirus and other intestinal pathogens are rarely diagnosed 
and mainly affect young children. Compared with rotavirus-bacterium association, rotavirus-virus associ-
ation is more commonly registered, its clinical course is milder, the prognosis of the disease is auspicious 
and the in-patient stay is shorter.
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INTRODUCTION
Infectious diarrhea continues to be an actual 
problem of modern medicine – 2.7 billion cases are 
registered globally on an annual basis, of which 1.7 
billion have a lethal outcome. The main risk group 
includes children under 5 years of age, in whom the 
intestinal infections become the reason for death in 
9% of the cases (1).
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verging. The demonstrated data vary from the lack of 
a synergistic effect between RV and other intestinal 
pathogens (6, 13, 14) to substantial presence of syn-
ergism between them (15, 16). The answer about the 
possibility for such interaction was sought in the tests 
on cell cultures and animalistic models. The majori-
ty of the in vitro experiments show that the co-infec-
tion of the cells with RV and various bacterial entero-
pathogens leads to an increase in bacterial invasive-
ness and their replication capacity (17,18,19), since 
RVs cause disorganization in the components of the 
cytoskeleton in intestinal cells (20). 
Undoubtedly, mixed infections and their com-
plex role in the pathogenesis of human diseases need 
additional research, especially when it comes to so-
cially significant diseases on a global scale, such as 
rotavirus infections.
AIM
To study the clinical course of mixed forms of 
RV infections with other viral and bacterial entero-
pathogens in children under 5 years of age, suffering 
from infectious diarrhea, we set the following tasks:
1. to obtain the frequency of occurrence of mixed 
forms of the infection: rotavirus-virus (RVVA) 
and rotavirus-bacterium associations (RVBA);
2. to study the characteristics of the course of RV 
co-infections, depending on the co-infecting 
agent.
MATERIALS AND METHODS
The disease history of 27 children aged 0 to 5 
years with mixed forms of RV infection with viral 
and bacterial enteropathogens, who were hospital-
ized in the Infectious Disease Clinic at Saint Mari-
na University Hospital, Varna in the period March, 
2016 – December, 2017, was analyzed retrospective-
ly. Their diagnoses were confirmed through culture 
methods for bacterial causative agents and immu-
nochromatographic methods for the viral ones. The 
clinical manifestations and laboratory changes in the 
course of the infectious disease in every patient were 
studied. Records from the medical databases of the 
clinic for the hospitalized patients in the period were 
used. 
In developed countries, viruses cause about 70% 
of episodes of infectious diarrhea, while bacteria and 
parasites lead to diarrhea in 20% and 10% of the cas-
es, respectively (2). Regardless of the World Health 
Organization’s (WHO) recommendation from 2009 
on the global use of the rotavirus vaccine (3), rotavi-
ruses (RVs) continue to cause the majority of cases 
of viral gastroenteritis in children on a global scale 
(4). In Europe, this leads to approximately 75,000-
150,000 hospitalizations of children under 5 years 
of age annually (5). In Bulgaria, the aforementioned 
tendency is preserved. In a study conducted by Mlad-
enova Z et al. on hospitalized children under 3 years 
of age with acute diarrhea, viruses caused diarrhea in 
75% of the cases, 62% of which were diagnosed as ro-
taviral gastroenteritis (RGE) (6). In a study by Stoeva 
Т et al. the incidence of viral causative agents in posi-
tive stool samples accounted for 66.7%, with leading 
share of RV - 50%, and the mixed types of intestinal 
infections were present in 4.87% of stool samples of 
children under 5 years of age (7).
As a result of the advancement of laboratory 
techniques, a high occurrence of RV co-infections 
with other enteropathogens has been established: 
bacteria, viruses, and parasites. Their incidence var-
ies widely from 0.3 to 45.5% depending on the geo-
graphical features, economic development, and sani-
tary culture of a given country, employed laboratory 
techniques and characteristics of the studied popula-
tion (8). In Bulgaria, epidemiologic studies have es-
tablished that the mixed types of intestinal infections 
in children under 3 years of age account for 27% of 
the cases with identified causative agent (6).  
In Europe, the mortality rate caused by RGE is 
at a low level: 0.1-0.2/100,000 (5). Moreover, compli-
cated variants of infection with severe course, which 
require long hospitalization, are present in over 15% 
of the cases (9). We have limited information about 
risk factors leading to complicated cases. The stud-
ies have proved the effect of the following: low body 
weight at birth, a nursery or preschool attendance 
and another child under 2 years of age in the fam-
ily (10,11,12). 
Irrespective of the high level of distribution of 
RV co-infections, studies reporting the characteris-
tics of their clinical course and degree of complex-
ity of a certain type of infection are limited and di-
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RESULTS
Six hundred eighteen children aged 0 to 5 years 
with acute intestinal infections were treated during 
10 months of 2016, 211 (34.14%) of them were diag-
nosed with RGE, in 5 (0.81%) cases mixed forms of 
the RV infection were observed. In 2017, out of a total 
of 615 children RGE was confirmed for 245 (39.84%) 
children, and the mixed forms were reported in 27 
(3.58%) of them (Fig. 1). The cases of mixed infec-
tions were registered throughout the year. As evident 
from the case history, all 27 children had been vac-
cinated in compliance with the Vaccine Schedule of 
the Republic of Bulgaria, but the specific vaccination 
against RV was never administered to any of them.
The mixed forms comprised an association of 
a rotavirus with another enteropathogenic virus or 
bacterium. According to this indication, the patients 
were divided into two groups: with RVVA (15 pa-
tients – 55.6%) and with RVBA (12 patients – 44.4%) 
(Fig. 2). 
In addition to RV in RVVA patients, we es-
tablished the presence of adenovirus in 6 patients 
(22.22%), norovirus in 6 patients (22.22%), and as-
trovirus in 3 patients (11.11%). In 3 cases, more than 
2 pathogens were identified (20%). The co-infecting 
agents in RVBA were as follows: Salmonella spp. in 4 
patients (14.81%), E. coli in 3 patients (11.11%), toxi-
genic strain of C. difficile in 3 patients (11%), and Shi-
gella spp. in 2 patients (7.41%).  
According to their age, the distribution of the 
patients was as follows: 
  patients with RVVA aged 0 to 1: 6 (40%), from 1 
to 3 years old: 7 (46.67%), from 3 to 5 years old: 
2 (13.33%);  
  patients with RVBA aged 0 to 1: 2 (16.67%), 
from 1 to 3 years old: 8 (66.67%), from 3 to 5 
year old: 2 (16.67%) (Fig. 3). 
We also calculated the average age of the pa-
tients depending on the type of co-infecting agent. 
The patients with RVVA were aged 20±14.3 months 
on average, and those with RVBA – 25±15.8 months.
The clinical manifestations of mixed infections 
in patients with RVVA and RVBA were studied. We 
established that the course of RVVA included fever, 
watery diarrhea and vomiting in 10 patients (66.67%), 
watery diarrhea and vomiting in 4 patients (26.67%), 
watery diarrhea and fever in only 1 patient (6.67%). 
RVBA patients were characterized by fever, watery 
diarrhea and vomiting in 5 cases (41.67%), watery 
diarrhea and vomiting in 2 patients (16.67%), wa-
tery diarrhea and fever in 5 patients (41.67%) (Fig. 4). 
Moreover, we found differences in the average tem-
perature upon admission: in patients with RVVA – 
37.9±1.1ºС, and in patients with RVBA – 38.3±0.97ºС. 
The frequency of the main occurrences of intestinal 
infection in the two groups in the first 24 hours was 
analyzed. In patients with RVVA the average number 
Fig. 1. The incidence of RV mono- and co-infections in the 
structure of acute intestinal infections in children aged 0 
- 5 years
Fig. 2. Distribution of the patients according to the type of 
co-infecting agent
Fig. 3. Age distribution of patients
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of vomits in the first 24 hours was 5.4±3.4, and the 
average number of defecations – 6.4±3.3. In patients 
with RVBA the tendency was as follows: the frequen-
cy of vomits equaled 2.42±3.1, whereas the average 
number of defecations was 6.33±3.1, and half of our 
patients complained of abdominal pain and presence 
of mucus and/or blood in the stool (50%). 
We compared the length of the hospital stay as 
well, depending on the type of co-infecting agent. In 
the case of RVVA it was from 0 to 5 days for 8 pa-
tients (53.33%), between 6 and 10 days for 5 patients 
(33.33%) and over 10 days for 2 (13.33%). The average 
hospital stay in this category was 6.53±3.46 days. The 
following was observed in the case of RVBA: only 
one patient (8.33%) stayed in hospital for 5 days, 7 
patients (58.33%) – between 6 and 10 days, 4 patients 
(33.33%) – over 10 days (Fig. 5). The average hospital 
stay of patients with RVBA was 10.1±3.73 days.
Presence of deviations in the acid-base balance 
(ABB) and the fluid and electrolyte balance (FEB) 
in our patients was analyzed and the following ten-
dency was identified. Four patients (26.67%) with 
RVVA had no changes in ABB and FEB, in 8 patients 
(53.33%) we observed data for decompensated met-
abolic acidosis (DMA), 2 patients (13.33%) demon-
strated data for hypokalemia, and 1 patient (6.67%) – 
data for hypochloremia. In the patients with RVBA: 
no complications regarding ABB and EB were ob-
served in 2 patients (16.67%), with data for DMA 
were 5 patients (41.67%), hypokalemia was present in 
2 patients (16.67%), and 3 patients (25%) had hypona-
tremia (Fig. 6).
The differences in markers of acute inflamma-
tion in our patients were reported. In patients with 
RVVA the average leukocyte count was 9.91±5.2·109/L, 
and the values of C-reactive protein (CRP) equaled 
9.07±11.86 mg/L. In the patients with RVBA, the av-
erage leukocyte count was 14.12±5.1·109/L, and CRP 
values were 31.5±48.59 mg/L.
DISCUSSION
In the period from March, 2016 to December, 
2017 there were 1,233 children with acute intestinal 
infections under 5 years of age treated at the Infec-
tious Disease Clinic in Varna. Four hundred fifty-
six children (36.98%) were diagnosed with RGE, and 
the diagnosis for mixed forms of RV infections with 
other intestinal enteropathogens was reported in 27 
cases (5.92%). The data correlates with global, Eu-
ropean and national tendencies, where RVs are the 
main causative agents of gastroenteritis in children 
under 5 years of age (4,21,22), and the frequency of 
Fig. 4. The clinical manifestations of RV infections, ac-
cording to the type of co-infecting agent
Fig. 5. Length of hospital stay
Fig. 6. Changes in ABB and FEB in patients with RVVA 
and RVBA
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occurrence of mixed infections with other intestinal 
pathogens is directly dependent on the sanitary and 
hygiene conditions of life in a given country and var-
ies widely (8). Sixteen (59.26%) of the patients studied 
by us belong to a part of the population with poor so-
cial and living conditions and low sanitary and hy-
giene culture.
The etiological diversity of viral and bacteri-
al co-infecting enteropathogens in our study most 
probably projects their epidemiological significance 
to Bulgaria as a developed country in the European 
Union. The number of patients with intestinal infec-
tions as a result of the mixed infection of RV with 
another viral enteropathogen prevail over the cases 
of mixed infections with bacterial enteropathogens 
(55.6% and 44.4% respectively), similarly to other de-
veloped countries – the viruses, as causative agents 
of intestinal infections, prevail over the bacterial en-
teropathogens in children under 5 years of age (2,22).
 In the structure of incidence of intestinal in-
fections, rotaviruses lead in terms of frequency of oc-
currence, followed by adenovirus, norovirus and as-
trovirus (23,24), with the exception of countries with 
high exposure of the population to the rotavirus vac-
cine, where norovirus has a leading role (25,26). An-
alogically, the presence of such co-infecting bacteri-
al enteropathogens, which are epidemiologically sig-
nificant to Europe: Salmonella spp., E. coli, C. diffi-
cile, Shigella spp., was established. The exception, 
which we determined contrary to the aforemen-
tioned tendency, is the lack of Campylobacter spp., 
which causes the most common zoonosis in the EU, 
among the isolates (27). The authors explain this fact 
with characteristics of the cultivation of Campylo-
bacter spp. Their requirements to the growing medi-
um are higher, and their growth is slower compared 
with other enterobacteria, which limits the routine 
study of this pathogen in every patient with infec-
tious diarrhea (28). 
The age distribution of the patients in our study 
does not differ from the generally known scientific 
data: according to the European Centre for Disease 
Prevention and Control (ECDC), RGE are mostly 
seen in children under 3 years of age (4). The major-
ity of the patients with the mixed forms of RGE with 
a bacterial enteropathogen belong to the age group 
of 1-3 years, unlike the cases of mixed forms of RGE 
with another viral enteropathogen, where the dis-
tribution of patients from age groups 0-1 years and 
1-3 years is almost uniform.  The authors presume 
this fact is explained with the characteristics relat-
ed to raising children: stricter hygiene, a narrower 
circle of contact people for infants and passive im-
munity in the first month of their life. By expand-
ing the diet and increasing the contacts, the oppor-
tunity for encountering a bacterial enteropathogen 
increases considerably. In addition, the fact that 23 
out of 27 studied patients were aged 0-3 confirms the 
scientific data for complicated RGE course which re-
quires hospitalization (both in monoinfections and 
mixed form cases) in children under 3 years of age 
(10,11,12). 
The clinical characteristics of RGE normally in-
clude a general toxic and infectious syndrome (with 
insignificantly expressed temperature response), as 
well as upper and lower dyspeptic syndromes (poten-
tially leading to dehydration and dyselectrolytemia) 
(29). Similar clinical indicators at a different level of 
manifestation are also observed in the patients with 
infectious diarrhea of noro-, adeno- and astroviral 
origin (30,31,32). Respectively, all our patients with 
mixed forms of RV infections with other viral en-
teropathogens complained of the symptoms above. 
Making a comparison with patients from another 
group, we also established another symptom in half 
of them – abdominal pain, and diarrhea stools con-
taining mucus and/or blood, which is typical of bac-
terial enteropathogens. Furthermore, a difference in 
the intensity of the main symptoms in the two groups 
in the first 24 hours after the admission was noticed. 
In almost equal number of defecations (6.4±3.3 and 
6.33±3.1 respectively), the patients suffering from 
mixed RV infection with another viral enteropatho-
gen had more cases of vomiting (5.4±3.4 compared to 
2.42±3.1) and not so expressed temperature response 
(37.9±1.1 ºС compared to 38.3±0.97 ºС). 
Both groups of studied patients demonstrat-
ed deviations from ABB and FEB (mainly in the pa-
tients from the second group with a bacterial co-in-
fecting enteropathogen). However, in our opinion, 
this fact is not due to the presence of the mixed infec-
tion, as an aggravating factor, but is explained by the 
characteristics of the studied sample of patients with 
the available symptoms for hospitalization at the In-
fectious Disease Clinic.
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RGE is a self-limiting disease whose duration is 
between 5 and 8 days (5). In 2012-2014, Gospodinova 
M, Todorov I et al., conducting a study on rotavirus 
infections, reported an average hospital stay of such 
patients of 6.37±1.21 days (33). In the present study, 
a similar result was obtained in patients with mixed 
forms of viral gastroenteritis (6.53±3.46 days). A dif-
ferent result was obtained for patients with mixed 
forms of RV infections with bacterial enteropatho-
gens: the symptoms in them persisted longer, and the 
average hospital stay was 10.1±3.73 days.
The treatment administered to all patients in-
cluded parenteral rehydration therapy and probi-
otics. The changes in ABB and FEB were adjusted 
when necessary. The antibiotic therapy (according to 
an antimicrobial susceptibility testing) was adminis-
tered to those patients with RVBA who had a colitis 
syndrome during the clinical course of the disease.
None of our patients had an RV vaccination. 
The positive effect of the specific immunization has 
already been proven conclusively (3,4,5), but it is 
an interesting fact that a number of studies report-
ed the benefit of the administration of the RV vac-
cine in cases of infection with another intestinal en-
teropathogen (34,35). In a placebo-controlled study 
by Pang XL et al. on children aged 50-110 days, 86 
of 1,528 episodes of diarrhea were predetermined 
by a monoinfection with adenoviruses and 12 – by 
mixed rotavirus-adenovirus infections. Compared 
to the placebo group, the children vaccinated against 
RV had shorter diarrhea duration, even in the cas-
es with adenoviral etiology of the disease (34). Simi-
lar results were also obtained in the course of anoth-
er study, where sapovirus-associated gastroenteritis 
cases had a considerably milder course in children 
vaccinated against RV (35).
CONCLUSIONS
In our study, we established that RGE still ac-
counts for a significant incidence of the pathology of 
intestinal infections in children under 5 years of age. 
Commonly mixed forms with other enteropathogens 
are registered. In our study the mixed forms of in-
testinal infection were registered in 5.59% of cases. 
The early childhood period is mostly affected with 
a prevalence of RVVA. The most common patho-
gens in mixed forms are adenovirus, norovirus and 
Salmonella spp. Leukocytosis and increased CRP re-
fer to RVBA. Complicated clinical course and longer 
hospital stay were observed in patients with RVBA 
with characteristic symptoms: body temperature 
>38.3°C; abdominal pain, blood and/or mucus in 
stool; the level of social and living conditions influ-
ences the diagnosis as well. Compared with RVBA, 
RVVA are commonly registered, their clinical course 
is milder, the prognosis of the disease is auspicious 
and the in-patient stay is shorter.
Respectively, the wide immunization of chil-
dren with a RV vaccine can contribute considerable 
benefits to society. Further studies would be useful 
in order to assess the effect of immunization on the 
mixed forms of RV infection.
The limited number of studied patients did not 
allow us to make a comparison between the clini-
cal course of RGE as a monoinfection and the mixed 
forms of RGE with other enteropathogens. As a re-
sult, a question remained unanswered: do intestinal 
pathogens act in synergy or antagonistically and, re-
spectively, how the presence of another enteropatho-
gen complicates RGE?  Further studies are necessary 
for a clearer understanding of this type of infection.
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